Journal of Medicinal Chemistry p. 4443 - 4453 (2009)
Update date:2022-08-04
Topics:
Liu, Weiguo
Liu, Kun
Wood, Harold B.
McCann, Margaret E.
Doebber, Thomas W.
Chang, Ching H.
Akiyama, Taro E.
Einstein, Monica
Berger, Joel P.
Meinke, Peter T.
A series of 3-acylindole-1-benzylcarboxylic acids were designed and synthesized while searching for a PPARγ modulator with additional moderate intrinsic PPARα agonistic activity. 2-[3-[[3-(4-Chlorobenzoyl)-2-methyl- 6-(trifluoromethoxy)-1H-indol-1-yl]methyl]phenoxy]-(2R)-butanoic acid (12d) was identified as such an agent which demonstrated potent efficacy in lowering both glucose and lipids in multiple animal models with significantly attenuated side effects such as fluid retention and heart weight gain associated with PPARγ full agonists. The moderate PPARα activity of 12d not only contributed to the agent's ability to manage lipid profiles but also appears to have potentiated its PPARγ efficacy in lowering glucose levels in preclinical diabetic animal models.
View MoreJinan Yijialian Economic and Trade Development Co., Ltd.
Contact:+86 0531-66729596
Address:jinan
shanghai hekang chemical co.ltd
Contact:021-54173790
Address:328 WuHe Road, Building #A, 2nd Floor, Minhang, Shanghai 201109, China
ChangZhou XiaQing Chemical Co., Ltd.
Contact:+86-519-88721665
Address:3# Hengluo Road, Henglin Town, Changzhou City, Jiangsu Province,China
Shijiazhuang Yunxuan Im&Export Co.,Ltd.
Contact:+86-311-83037514
Address:No.6 Hongbin Road
Changzhou LanXu Chemical Co.,ltd.
Contact:86-0519-86330911,13656129734,15261186386
Address:Room 524, Depart.Chemical, Changzhou Science and Eductaion town, Jiangsu, China;Factory: Haian Fine Chemical Industry Park,Nantong,Jiangsu,China
Doi:10.1002/anie.200352464
(2004)Doi:10.1039/P19960002213
(1996)Doi:10.1039/c39860000198
(1986)Doi:10.1021/ja056741n
(2006)Doi:10.1002/hlca.200390339
(2003)Doi:10.1007/BF00673330
()